Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine with or without Radiation Therapy in Localized, Unresectable Pancreatic Cancer
NCT00057876Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Aug 2003
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of gemcitabine in pancreatic cancer (PC) (2 arms), sponsored by Eastern Cooperative Oncology Group. Primary endpoint: Overall Survival. Started Aug 2003; status: completed.
02
Drugs
gemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00057876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057876.